What is SBH Sciences?
SBH Sciences is a biotechnology firm with over 28 years of experience, dedicated to providing specialized products and services for discovery research, startup companies, and the broader biotechnology industry. Their offerings encompass cell-based assays, biomarker services, and drug discovery support, leveraging advanced technologies. The company supplies high-quality research products, including recombinant cytokines, monoclonal antibodies, and enzymes, to a diverse clientele of entrepreneur scientists and biotech firms seeking innovative R&D solutions.
How much funding has SBH Sciences raised?
SBH Sciences has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for SBH Sciences?
The substantial late-stage funding indicates SBH Sciences is poised for significant expansion and further development of its biotechnology solutions. This strategic investment will likely fuel advancements in their product portfolio and service capabilities, potentially enabling them to scale operations, enhance their technological infrastructure, and broaden their market reach within the competitive biotech landscape. The company's focus on supporting early-stage research and drug discovery positions it for continued relevance and impact.
See full SBH Sciences company page
